Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory W Daniel

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Journal of Managed Care Pharmacy : JMCP|November 1, 2007
LDL-C goal attainment among patients newly diagnosed with coronary heart disease or diabetes in a commercial HMOSoma S Nag, Gregory W Daniel, Michael F Bullano, et al.
Pharmacoepidemiology and Drug Safety|July 13, 2010
Cardiovascular safety of ADHD medications: rationale for and design of an investigator-initiated observational studySean Hennessy, Hedi Schelleman, Gregory W Daniel, et al.
American Journal of Epidemiology|October 27, 2012
Characterizing vaccine-associated risks using cubic smoothing splinesM Alan Brookhart, Alexander M Walker, Yun Lu, et al.
Pharmacoepidemiology and Drug Safety|April 28, 2012
Validation of a claims-based diagnostic code for Stevens-Johnson syndrome in a commercially insured populationDebra F Eisenberg, Gregory W Daniel, Judith K Jones, et al.
The American Journal of Managed Care|February 15, 2019
Value-based arrangements may be more prevalent than assumedNirosha Mahendraratnam, Corinna Sorenson, Elizabeth Richardson, et al.
Drug Safety|February 11, 2014
Near-real-time monitoring of new drugs: an application comparing prasugrel versus clopidogrelJoshua J Gagne, Jeremy A Rassen, Niteesh K Choudhry, et al.
The American Journal of Psychiatry|February 10, 2012
Methylphenidate and risk of serious cardiovascular events in adultsHedi Schelleman, Warren B Bilker, Stephen E Kimmel, et al.
Plos One|February 6, 2013
Amphetamines, atomoxetine and the risk of serious cardiovascular events in adultsHedi Schelleman, Warren B Bilker, Stephen E Kimmel, et al.
Pediatrics|May 18, 2011
Cardiovascular events and death in children exposed and unexposed to ADHD agentsHedi Schelleman, Warren B Bilker, Brian L Strom, et al.
Pharmacoepidemiology and Drug Safety|January 21, 2012
A protocol for active surveillance of acute myocardial infarction in association with the use of a new antidiabetic pharmaceutical agentBruce Fireman, Sengwee Toh, Melissa G Butler, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Managed Care Pharmacy : JMCP|November 1, 2007
LDL-C goal attainment among patients newly diagnosed with coronary heart disease or diabetes in a commercial HMOSoma S Nag, Gregory W Daniel, Michael F Bullano, et al.
Pharmacoepidemiology and Drug Safety|July 13, 2010
Cardiovascular safety of ADHD medications: rationale for and design of an investigator-initiated observational studySean Hennessy, Hedi Schelleman, Gregory W Daniel, et al.
American Journal of Epidemiology|October 27, 2012
Characterizing vaccine-associated risks using cubic smoothing splinesM Alan Brookhart, Alexander M Walker, Yun Lu, et al.
Pharmacoepidemiology and Drug Safety|April 28, 2012
Validation of a claims-based diagnostic code for Stevens-Johnson syndrome in a commercially insured populationDebra F Eisenberg, Gregory W Daniel, Judith K Jones, et al.
The American Journal of Managed Care|February 15, 2019
Value-based arrangements may be more prevalent than assumedNirosha Mahendraratnam, Corinna Sorenson, Elizabeth Richardson, et al.
Drug Safety|February 11, 2014
Near-real-time monitoring of new drugs: an application comparing prasugrel versus clopidogrelJoshua J Gagne, Jeremy A Rassen, Niteesh K Choudhry, et al.
The American Journal of Psychiatry|February 10, 2012
Methylphenidate and risk of serious cardiovascular events in adultsHedi Schelleman, Warren B Bilker, Stephen E Kimmel, et al.
Plos One|February 6, 2013
Amphetamines, atomoxetine and the risk of serious cardiovascular events in adultsHedi Schelleman, Warren B Bilker, Stephen E Kimmel, et al.
Pediatrics|May 18, 2011
Cardiovascular events and death in children exposed and unexposed to ADHD agentsHedi Schelleman, Warren B Bilker, Brian L Strom, et al.
Pharmacoepidemiology and Drug Safety|January 21, 2012
A protocol for active surveillance of acute myocardial infarction in association with the use of a new antidiabetic pharmaceutical agentBruce Fireman, Sengwee Toh, Melissa G Butler, et al.
Pageof 3